Recommended in Thoracic Medicine

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
  • The New England Journal of Medicine
  • 1 comment
  • FULLTEXT

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

Nivolumab was not as effective as chemotherapy in patients with lung cancer whose tumors had PD-L1 expression of at least 5%.

Read more
  • Clinical summaries
  • 1 comment

COPD: Do beta-blockers influence exacerbation rates in high-risk patients?

Read more
  • Clinical Essentials from Cochrane Database Syst Rev
  • 1 comment
  • FULLTEXT

Cochrane review: umeclidinium in COPD

Read more
  • The Lancet
  • 1 comment
  • FULLTEXT

Unbiased, credible data on violence against health care in Syria

Read more
  • Clinical summaries
  • 1 comment

Chest radiography based diagnosis of mild COPD may require further confirmation

Read more
  • The New England Journal of Medicine
  • 1 comment
  • FULLTEXT

Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer

Read more
  • elsevier_the_lancet_pneumology_jp_review
  • no comment
  • FULLTEXT

ARDS: Identifying new effective therapies

Read more
  • Univadis
  • 1 comment

ASCO 2017 - Advanced SCLC: promising results with nivolumab±ipilimumab

Read more
  • Univadis
  • 1 comment

ASCO 2017 - NSCLC: phase 3 study suggests prolonged survival benefit with atezolizumab

Read more

Professional & Business

  • International Medical Press

Call for improved GP resources as postnatal depression missed

Read more
  • International Medical Press

BMA: government fails to acknowledge NHS ‘at breaking point’

Read more
  • International Medical Press

RCOG outlines steps to prevent baby deaths and injuries during birth

Read more
  • International Medical Press

Study clarifies cancer risk for BRCA gene mutations

Read more
  • International Medical Press

Medicine information leaflets too complex, say experts

Read more
  • International Medical Press

NHS appeal for more black people to give blood

Read more
View more

New in Thoracic Medicine

Only 16% of patients with asthma completely adherent | EAACI
  • Conference reports - RSi Communications
  • 1 comment

Only 16% of patients with asthma completely adherent | EAACI

Study highlights need for stronger belief that benefits outweigh potential harm.

Read more
  • Clinical Essentials from Crit Care
  • 1 comment

Varicella-associated pneumonia: do adjunctive steroids help or hurt?

Data from the largest study on VZV-CAP.

Read more
  • Clinical Essentials from JAMA Oncol
  • 1 comment

NSCLC: delayed adjuvant chemotherapy shows benefit

Adjuvant chemotherapy is effective even when started 7-18 wk post-resection.

Read more
  • Clinical Essentials from Invest New Drugs
  • 1 comment

ES-SCLC: amrubicin is a viable treatment option for certain patients

Phase 2 data show benefit in chemotherapy-naive elderly, poor-risk patients.

Read more
Medicine information leaflets ‘impenetrable’ and ‘unreadable’
  • Univadis Medical News
  • no comment

Medicine information leaflets ‘impenetrable’ and ‘unreadable’

A new report calls for major changes to medicine patient information leaflets.

Read more
  • Clinical Essentials from Cancer Epidemiol Biomarkers Prev
  • 1 comment

HIV: increased cancer screening may be warranted

People with HIV are living full lives on ART, opening the door for new causes of death.

Read more
Grass pollen SLIT lowers risk of asthma onset and progression | EAACI
  • Conference reports - RSi Communications
  • 1 comment

Grass pollen SLIT lowers risk of asthma onset and progression | EAACI

Asthma progression improved by 24.6% during treatment and 15.2% after cessation.

Read more
PCV13 vaccine immune response tops PPSV23 in CLL | EHA
  • Conference reports - RSi Communications
  • 1 comment

PCV13 vaccine immune response tops PPSV23 in CLL | EHA

Immune response superior in 10 out of 12 serotypes after one month.

Read more
  • Clinical Essentials from Clin Microbiol Infect
  • 1 comment

Pneumonia in nursing homes: simple severity prediction tool

Study provides a simple tool to individualize the treatment of NHAP.

Read more
  • Clinical Essentials from Lung Cancer
  • no comment

SCLC: no benefit for toxicity-adjusted cisplatin-etoposide dosing

Results of the phase 3 STAD-1 trial.

Read more
  • Clinical Essentials from Chest
  • 1 comment

Chest Expert Cough Panel: recommendations on chronic cough in children

The most common etiologies vary according to age and location.

Read more
BMJ and Oxford University target 'questionable integrity' of medical research
  • Univadis Medical News
  • 1 comment

BMJ and Oxford University target 'questionable integrity' of medical research

The Evidence-Based Medicine Manifesto aims to develop more trustworthy evidence to improve healthcare.

Read more
Infections in early infancy could increase future risk for coeliac disease
  • Univadis Medical News
  • 1 comment

Infections in early infancy could increase future risk for coeliac disease

Risk pronounced with infections in the first year of life.

Read more
European doctors back cycling strategy
  • Univadis Medical News
  • 1 comment

European doctors back cycling strategy

Organisations across Europe, including the Standing Committee of European Doctors, have called on the European Commission to develop an EU cycling strategy.

Read more